(Q46846959)

25 December 2017

title

Switching the therapy from etanercept to infliximab in a child with rheumatoid factor positive polyarticular juvenile idiopathic arthritis (English)

1 reference

25 December 2017

juvenile rheumatoid arthritis

main subject

1 reference

Yasuhito Nerome

1

1 reference

25 December 2017

Hiroyuki Imanaka

series ordinal

2

1 reference

25 December 2017

Yukiko Nonaka

series ordinal

3

1 reference

25 December 2017

Syuji Takei

series ordinal

4

1 reference

25 December 2017

publication date

20 December 2007

1 reference

25 December 2017

published in

Modern Rheumatology

1 reference

25 December 2017

volume

17

1 reference

25 December 2017

issue

6

1 reference

25 December 2017

page(s)

526-528

1 reference

25 December 2017

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis

cites work

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0634-3

Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0634-3

Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0634-3

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2FS10165-007-0634-3

10.3109/S10165-007-0634-3

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017